96 related articles for article (PubMed ID: 22076778)
1. Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts.
Safari F; Hajizadeh S; Shekarforoush S; Bayat G; Foadoddini M; Khoshbaten A
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):29-35. PubMed ID: 22076778
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
3. Expressional profile of cardiac uncoupling protein-2 following myocardial ischemia reperfusion in losartan- and ramiprilat-treated rats.
Safari F; Bayat G; Shekarforoush S; Hekmatimoghaddam S; Anvari Z; Moghadam MF; Hajizadeh S
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):209-17. PubMed ID: 23372044
[TBL] [Abstract][Full Text] [Related]
4. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
6. Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor.
Zhu B; Sun Y; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):129-33. PubMed ID: 11881112
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
[TBL] [Abstract][Full Text] [Related]
8. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke.
Zhu BQ; Sievers RE; Browne AE; Hillman RT; Chair K; Lee RJ; Chatterjee K; Glantz SA; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):54-60. PubMed ID: 11984749
[TBL] [Abstract][Full Text] [Related]
11. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
Hartman JC; Hullinger TG; Wall TM; Shebuski RJ
Eur J Pharmacol; 1993 Apr; 234(2-3):229-36. PubMed ID: 8482328
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
[TBL] [Abstract][Full Text] [Related]
13. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
14. [Protective effects of losartan against myocardial ischemic reperfusion in intact canine].
Yang Y; Huo ZC; Peng J; Jia MY; Huang Z; Wang ZM; Chen YL
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):580-1. PubMed ID: 15897143
[TBL] [Abstract][Full Text] [Related]
15. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
[TBL] [Abstract][Full Text] [Related]
17. Chemical preconditioning effect of 3-nitropropionic acid in anesthetized rat heart.
Turan NN; Basgut B; Aypar E; Ark M; Iskit AB; Cakici I
Life Sci; 2008 Apr; 82(17-18):928-33. PubMed ID: 18387637
[TBL] [Abstract][Full Text] [Related]
18. Losartan protects the heart against ischemia reperfusion injury: sirtuin3 involvement.
Klishadi MS; Zarei F; Hejazian SH; Moradi A; Hemati M; Safari F
J Pharm Pharm Sci; 2015; 18(1):112-23. PubMed ID: 25877446
[TBL] [Abstract][Full Text] [Related]
19. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Gandhi C; Upaganalawar A; Balaraman R
Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067
[TBL] [Abstract][Full Text] [Related]
20. Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine.
Laudi S; Weimann J; Haschke M; Trump S; Schmitz V; Christians U; Kaisers U; Steudel W
J Physiol Pharmacol; 2007 Mar; 58(1):19-32. PubMed ID: 17440223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
